Takeda Pharmaceutical Co Ltd

JP

TAKDA

Health Care

13.36 ₽

Current price

Hold
13.36 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    639 / 1328

  • Position in country

    3619 / 4811

  • Return on Assets, %

    1.2

    -2.7

  • Net income margin, %

    9.5

    2.8

  • EBITDA margin, %

    28.5

    10.8

  • Debt to Equity, %

    69.1

    19.2

  • Intangible assets and goodwill, %

    64.7

    3.6

  • Revenue CAGR 3Y, %

    6.9

    8.5

  • Total Equity change 1Y, %

    1.4

    0

  • Revenue Y, % chg

    -0.8

    0.5

  • P/E

    36.3

    22.7

  • P/BV

    0.9

    1.5

  • P/S

    1.5

    2.3

  • EV/S

    2.6

    2.4

  • EV/EBITDA

    9.3

    7.4

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    34.6

    51.3

  • Forward P/E

    29

    15.6

  • Dividend Yield, %

    7.1

    1.7

  • Forward Dividend Yield, %

    5

    0.2

  • Expected dividend per share

    0.6

    0

  • Payout Ratio, %

    161.8

    30.3

Get an analytical review of this company

Competitors

Ranks

  • Daiichi Sankyo Co Ltd

    00%

  • Ono Pharmaceutical Co Ltd

    00%

  • Kyowa Kirin Co Ltd

    00%

  • Shionogi & Co Ltd

    00%

  • Taisho Pharmaceutical Holdings Co Ltd

    00%

  • Chugai Pharmaceutical Co Ltd

    00%

  • Takeda Pharmaceutical Co Ltd

    00%

  • Eisai Co Ltd

    00%

  • Otsuka Holdings Co Ltd

    00%

  • Astellas Pharma Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Japan

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    42804.6

  • Ticker

    TAK.N

  • ISIN

    US8740602052

  • IPO date

    1949-05-16

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-02

  • Date fact. publication of reports

    2023-12-31

Company Description

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: